Thrombogenics N.V.
Records under this name other than the patents Thrombogenics N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,445,775 | Yeast Expression Vector and a Method of Making a Recombinant Protein by Expression in a Yeast Cell Formerly held Term ended Term ended Oct 17, 2026 · High confidence | Term ended | Term ended Oct 17, 2026 | High confidence |
| US 8,758,748 | Anti-Angiogenic Therapy Formerly held Lapsed on the fee record Ended Jun 24, 2026 · High confidence | Lapsed on the fee record | Ended Jun 24, 2026 | High confidence |
| US 8,460,655 | Pharmacological Vitreolysis Formerly held Lapsed on the fee record Ended Jun 11, 2025 · Medium confidence | Lapsed on the fee record | Ended Jun 11, 2025 | Medium confidence |
| US 9,445,078 | Stereo-vision system Lapsed on the fee record Ended Sep 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2024 | From the USPTO record |
| US 7,547,435 | Pharmacological Vitreolysis Formerly held Term ended Term ended Jun 5, 2024 · High confidence | Term ended | Term ended Jun 5, 2024 | High confidence |
| US 8,383,105 | Pharmacological Vitreolysis Formerly held Term ended Term ended Apr 19, 2024 · High confidence | Term ended | Term ended Apr 19, 2024 | High confidence |
| US 9,770,494 | Pharmacological Vitreolysis Formerly held Term ended Ended no later than Dec 5, 2023 · Medium confidence | Term ended | Ended no later than Dec 5, 2023 | Medium confidence |
| US 9,186,394 | Pharmacological Vitreolysis Formerly held Lapsed on the fee record Ended Nov 17, 2023 · Medium confidence | Lapsed on the fee record | Ended Nov 17, 2023 | Medium confidence |
| US 9,089,552 | Improving trabeculectomy outcome by administering an anti-placental growth factor antibody Formerly held Lapsed on the fee record Ended Jul 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | From the USPTO record |
| US 9,085,617 | Anti-Angiogenic Therapy Formerly held Lapsed on the fee record Ended Jul 21, 2023 · High confidence | Lapsed on the fee record | Ended Jul 21, 2023 | High confidence |